rs121918069
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000237014.8(TTR):c.233T>A(p.Leu78His) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L78R) has been classified as Pathogenic.
Frequency
Genomes: not found (cov: 32)
Consequence
TTR
ENST00000237014.8 missense
ENST00000237014.8 missense
Scores
12
6
1
Clinical Significance
Conservation
PhyloP100: 6.06
Genes affected
TTR (HGNC:12405): (transthyretin) This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PM1
In a hotspot region, there are 13 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in ENST00000237014.8
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr18-31595152-T-G is described in ClinVar as [Pathogenic]. Clinvar id is 13435.Status of the report is no_assertion_criteria_provided, 0 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.975
PP5
Variant 18-31595152-T-A is Pathogenic according to our data. Variant chr18-31595152-T-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 13420.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-31595152-T-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTR | NM_000371.4 | c.233T>A | p.Leu78His | missense_variant | 3/4 | ENST00000237014.8 | NP_000362.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTR | ENST00000237014.8 | c.233T>A | p.Leu78His | missense_variant | 3/4 | 1 | NM_000371.4 | ENSP00000237014 | P1 | |
TTR | ENST00000649620.1 | c.233T>A | p.Leu78His | missense_variant | 5/6 | ENSP00000497927 | P1 | |||
TTR | ENST00000610404.5 | c.137T>A | p.Leu46His | missense_variant | 3/4 | 5 | ENSP00000477599 | |||
TTR | ENST00000541025.2 | n.259T>A | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Sep 09, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 06, 2024 | Identified in association with amyloidosis and amyloidotic polyneuropathy; also reported as L58H due to alternative nomenclature (PMID: 20209591, 2613237, 26656838, 27724962, 34658264, 34461735, 33283548); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 1644839, 17503405, 19602727, 22620962, 25526974, 2613237, 27724962, 17143887, 1656975, 25604431, 26656838, 34461735, 34658264, 33283548, 37014422, 20209591, 15820680) - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 25, 2016 | - - |
Amyloidosis, hereditary systemic 1 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change replaces leucine, which is neutral and non-polar, with histidine, which is basic and polar, at codon 78 of the TTR protein (p.Leu78His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) (PMID: 2613237, 9196903, 17503405, 20209591, 25526974, 27724962). This variant is also known as p.Leu58His. ClinVar contains an entry for this variant (Variation ID: 13420). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TTR protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects TTR function (PMID: 15820680, 19602727). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | May 31, 2022 | _x000D_ Criteria applied: PS3, PM2_SUP, PM1_SUP, PM5, PS4_MOD - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 27, 2001 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 10, 2016 | Variant summary: The TTR c.233T>A (p.Leu78His) variant indicated to be located in the loop region (Cendron_2009) causes a missense change involving a conserved nucleotide with 4/4 in silico tools (SNPs&GO not captured due to low reliability index) predict a damaging outcome for this variant. In addition, mutations in this residue (L78R) and in nearby residues (H76R, G77R, T79R, T79K) have been reported in association with amyloidosis, further supporting the functional importance of this region of the protein. The variant of interest was not observed in controls (ExAC, 1000 Gs, or ESP) and is a common TTR disease variant that is reported to be detected in >50 published cases, usually presenting with carpal tunnel syndrome and slowly progressing over two decades (Miller_2004). Multiple clinical diagnostic laboratories/databases cite the variant as "pathogenic." Therefore, the variant of interest has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 24, 2021 | The p.L78H variant (also known as c.233T>A and L58H), located in coding exon 3 of the TTR gene, results from a T to A substitution at nucleotide position 233. The leucine at codon 78 is replaced by histidine, an amino acid with similar properties. This alteration has been seen in multiple individuals with familial transthyretin amyloidosis whose symptoms generally included carpal tunnel syndrome, generalized neuropathy, amyloid deposits and positive congo red staining (Nichols WC, et al. Genomics 1989;5(3):535-40; Barreiros AP, et al. Liver Transpl. 2010;16(3):314-23; Connors LH, et al. Biochim. Biophys. Acta 1998;1407(3):185-92; Ungerer MN et al. Amyloid, 2020 Dec;:1-9). In two additional studies, a small difference in the crystal structure of this variant compared with wild type was noted and the variant was shown to unfold 90% at 2.5M urea, indicating decreased conformation stability in the folded state (Altland K, et al. Electrophoresis 2007;28(12):2053-64; Cendron L, et al. J. Biol. Chem. 2009 Sep; 284(38):25832-41). Based on internal structural analysis, this variant is anticipated to result in a significant decrease in structural stability (Zhang J et al. Environ Sci Technol, 2018 10;52:11865-11874). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;H;.;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;.;.
REVEL
Pathogenic
Sift
Uncertain
.;D;.;.
Sift4G
Uncertain
.;D;D;D
Polyphen
D;D;.;.
Vest4
0.92, 0.91, 0.95
MVP
0.99
MPC
1.6
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at